Exane Asset Management Legend Biotech Corp Transaction History
Exane Asset Management
- $142 Million
- Q4 2024
A detailed history of Exane Asset Management transactions in Legend Biotech Corp stock. As of the latest transaction made, Exane Asset Management holds 67,782 shares of LEGN stock, worth $2.58 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
67,782Holding current value
$2.58 Million% of portfolio
1.55%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.6MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$425 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$286 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$253 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$218 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$192 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...